NCT06027034Completed
Effectiveness of a Digital Health Application for Psoriasis
Effectiveness of a Digital Health Application for Psoriasis: Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 16 Jun 2026
Brief summary (registry, in English)
This clinical trial with 348 patients with psoriasis aims to investigate the effectiveness of a self-guided online program for patients with psoriasis. Patients will be randomized and allocated in a 1:1 ratio to either an intervention group, in which they will receive 12-month-access to an online program for psoriasis in addition to treatment as usual (TAU, n = 174), or to a control group, in which they will receive only TAU (n = 174). TAU is defined as any therapy prescribed or recommended by the GP or specialists (e.g. dermatologist, psychiatrist), which may include topical therapy, phototherapy, pharmacotherapy, psychosocial therapy, etc.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 348 (actual)
- First submitted
- 31 Aug 2023
- Start date
- 4 Sept 2023
- Primary completion date
- 31 Dec 2024
- Lead sponsor
- Gaia AG
- Diseases
- Psoriasis
- NCT number
- NCT06027034
What you commit to
- Study type: Interventional
- Participants enrolled: 348
- From 4 Sept 2023 to the primary completion date, 31 Dec 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Presence of another subtype of psoriasis (pustular psoriasis, guttate psoriasis, inverse psoriasis, erythrodermic psoriasis, or drug-induced psoriasis) or psoriatic arthritis without skin involvement
Other illness
- Presence of malignancies
- Presence of other chronic diseases with strong negative influence on quality of life
- Currently undergoing psychiatric treatment / current presence of a severe psychiatric diagnosis
Other
- Insufficient language and/or IT skills
Who the study is looking for
- Age ≥ 18 years
- Presence of psoriasis vulgaris or psoriatic arthritis
- Submission of a specialist medical certificate attesting to the presence of at least one of the following ICD-10-GM diagnoses: Psoriasis vulgaris (L 40.0, L 40.7), Psoriatic arthritis (L40.5, M07.x)
- Impaired health-related quality of life (DLQI \> 10)
- Consent to participate
- Sufficient understanding of the German language
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| GAIA AG Coordinator of this site? Confirm its status | Hamburg | Germany | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.